ClinicalTrials.govpublic full text
HCMT/MM2401: Ph2 Study of Selinexor + Bispecific Antibody for RRMM
multiple myeloma in relapse, multiple myeloma, refractory, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 844097
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.